ViaNautis

ViaNautis develops a proprietary nanomedicine platform for targeted intracellular drug delivery.

Cambridge, UK

$25.0MTotal raised

ViaNautis is a Cambridge-based nanomedicine company that develops advanced polymer platforms for targeted intracellular drug delivery.

Founders

Francesca Crawford

CEO

Denis Cecchin

Giuseppe Battaglia

Inventor of polyNaut and honorary professor at UCL

Investors

4BIO CapitalLead

BGFLead

UCB VenturesLead

Cystic Fibrosis Foundation

Eli Lilly and Company

Origin Capital

Meltwind

Funding history

Series A13 November 2023

$25.0M

ViaNautis secures $25m in Series A funding from 4BIO Capital, BGF, and UCB Ventures to advance its nanomedicine platform

The Cambridge-based nanomedicine developer has raised capital to expand its laboratory facilities and accelerate product development for its polyNaut technology.